At the Association for Research in Vision and Ophthalmology (ARVO) annual meeting, the Eye Care Network caught up with Jogin Desai. Dr. Desai is the founder of Eyestem Research, a biotechnology ...

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...

Image Credit: Newcells Biotech A two-dimensional in vitro model of retinal pigment epithelial cells derived from human induced pluripotent stem cells that replicate the phagocytosis of outer ...

Boehringer Ingelheim has started a proof-of-concept trial of a drug that could offer the first oral treatment for geographic ...

Amir Kashani, University of Southern California The implant, given to five patients with dry age-related macular degeneration (AMD), is a single sheet of retinal pigment epithelial (RPE) cells derived ...

Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem ...

Unlike humans, embryonic chicks demonstrate a remarkable ability to regenerate their neural retina by activating neural progenitors of the ciliary margin (CM) and through retinal pigment epithelium ...

Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 5.08%, which has investors questioning if this is right time ...

Another said there is a lack of high-level evidence in this area. SEVILLE, Spain — Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to ...

Retinal degeneration is a leading cause of blindness globally and results from irreversible damage to photoreceptors and supporting cells including retinal pigment epithelium (RPE). Scientists have ...

Cognition Therapeutics (CGTX) reported preclinical data this week at the Association for Research in Vision and Ophthalmology showing the ...